Yazar "Toz, Pinar Kuyum" seçeneğine göre listele

Listeleniyor 1 - 1 / 1
  • Küçük Resim
    Öğe
    A different starting line for allergic march: food protein-induced allergic proctocolitis
    (Codon Publications, 2023) Bahceci, Semiha; Toz, Pinar Kuyum; Celik, Figen Celebi; Can, Demet
    Objective: The aim of this study is to investigate the long-term prognosis of food protein-induced allergic proctocolitis (FPIAP) patients, the risk of developing both allergic and gastrointestinal diseases, and to evaluate whether it leads to allergic march. Methods: A total of 149 children who were diagnosed with FPIAP and developed tolerance at least 5 years prior to the study and 41 children (with no history of food allergy) as a control group were enrolled. Both groups were re-evaluated for allergic diseases as well as gastrointestinal disorders. Results: The mean age of diagnosis for the FPIAP group was 4.2 +/- 3.0 months, while the mean age of tolerance was 13.9 +/- 7.7 months. The mean age of both FPIAP and control groups at the last visit was 101.6 +/- 24.4 and 96.3 +/- 24.1 months, respectively (P = 0.213). At the final evaluation of both groups, the comorbid allergic disease was significantly higher in the FPIAP group (P < 0.001). There was no significant difference between the two groups in terms of functional gastrointestinal disorders (FGIDs), eosinophilic gastrointestinal diseases, and inflammatory bowel disease (P = 0.198, 0.579, and 0.579, respectively). In the FPIAP group, the allergic disease was significantly higher at the final visit in patients with comorbid allergic disease at diagnosis (P < 0.001). In the FPIAP group, FGID was significantly higher in the group that developed allergic diseases in the future, compared to the group that did not develop allergic diseases in the future (P = 0.034). The proportion of both FGID and allergic diseases was significantly higher in subjects that developed tolerance at >18 months, compared to subjects that developed tolerance at =18 months (P < 0.001 and < 0.001, respectively). Conclusions: Patients with FPIAP may develop allergic diseases as well as FGID in the long term. (c) 2023 Codon Publications. Published by Codon Publications.